Login / Register The Most Trusted Name in Medical Education

Genetics & Genomics

Elsevier's CME courses target medical geneticists with the need for the latest genetic and genomic knowledge.

Elsevier LSD Exchange 2018 02 Web 116x142

Focus on Lysosomal Diseases: New Frontiers for Accelerating Diagnosis and Optimizing Treatment

Format: Webcast

This webcast is based on a roundtable discussion on the optimal diagnosis and future management of lysosomal diseases. Three experts specializing in Fabry, Gaucher, and Pompe disease will raise key clinical questions and discuss how to overcome barriers in daily clinical practice across the lysosomal disease spectrum. The experts will provide an update on the long-term effects of ERT and highlight the remaining challenges, including the consequences of delayed diagnosis. They will discuss the role and importance of early diagnosis and treatment initiation, and provide perspectives on the recent advances in screening programs for newborn and high-risk populations. Lastly, the experts will address the position of emerging therapies and strategies for the optimal management of lysosomal diseases. 

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
910777 116 x 140

AAN 2018: An Update on Scientific Advances and Clinical Strategies in Alzheimer’s Disease

Format: Conference Reporter

The American Academy of Neurology (AAN) Annual Meeting was held in Los Angeles, California, April 21-27, 2018.  The AAN annual meeting is the largest international gathering of neurologists and neuroscience professionals. In this activity, 2 experts summarize the key learnings from this year’s conference focusing on Alzheimer’s disease (AD).

Take Course »

Credits: 0.75 AMA PRA Category 1 Credit™
Elsevier LSD Exchange 2018 02 Web 116x140 thumbnail 1

The Fabry Exchange: Optimizing Diagnosis and Treatment Initiation

Format: Webcast

This webcast was recorded during a live symposium at the WORLDSymposium Meeting in San Diego, CA, USA, on February 7, 2018. During the symposium, experts from around the world discussed the key clinical questions and controversies in the diagnosis of Fabry disease and the future direction of clinical management. They also addressed the consequences of delayed diagnosis and treatment initiation, provided guidance on understanding available diagnostic options, and discussed genotype–phenotype correlations and their significance for daily clinical practice.

Take Course »

Credits: 1.00 AMA PRA Category 1 Credit(s)™